Coronavirus Update: Ex-GSK Exec To Lead Trump's Operation Warp Speed
Moncef Slaoui Confident Of 2020 Goal
Executive Summary
US government will fund 'at risk' manufacturing of lead vaccine candidates, with Trump promising US will get priority. But skeptics say year-end timeline is unrealistic.
You may also be interested in...
Coronavirus Update: $8bn International Fund For Vaccines Created
Plus: Eli Lilly extends its presence in COVID-19 research with an alliance with China's Junshi Biosciences.
Executives On The Move: Changes At The Top At Enzolytics, Dyne Therapeutics And Seres Therapeutics
Recent moves in the industry include new chief financial officers at LENZ Therapeutics and Botanix Pharmaceuticals, plus new chief medical officers at Vigil Neuroscience and Voyager Therapeutics.
Pipeline Watch: 16 Approvals And 21 Phase III Trial Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.